title: Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation.
authors.forename: A
authors.initials: A
authors.lastname: Ikeda
authors.forename: H
authors.initials: H
authors.lastname: Hattori
authors.forename: A
authors.initials: A
authors.lastname: Odani
authors.forename: J
authors.initials: J
authors.lastname: Kimura
authors.forename: H
authors.initials: H
authors.lastname: Shibasaki
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D008297:Male; D008661:Metabolism, Inborn Errors / Q000235:genetics*; D010672:Phenytoin / Q000009:adverse effects*; D017354:Point Mutation / Q000235:genetics*; D000078305:Zonisamide
chemical_list: D000927:Anticonvulsants; D007555:Isoxazoles; D000078305:Zonisamide; D010672:Phenytoin